Art by Sophia Zhao. As scientists learn about the various effects of the SARS-CoV-2 pathogen on the body, researchers at UPenn and Johns Hopkins might
Art by Sophia Zhao. COVID-19 is a fickle foe, exhibiting mild symptoms in some individuals, severe pain and pneumonia in others, or in forty percent
Image courtesy of Flickr. Researchers from Massachusetts Institute of Technology (MIT) have recently developed a machine learning method called OptiVax to evaluate the effectiveness of
Artwork by Sophia Zhao. The results of the Moderna SARS-CoV-2 vaccine phase 1 clinical trial published last week have sparked new optimism in the race
Artwork by Sophia Zhao. In addition to their longevity, bats seem to be able to host deadly diseases such as Ebola, rabies and most recently
Image courtesy of Flickr. As no treatment has been shown to effectively combat the SARS-COV-2 virus yet, looking towards existing drugs may hasten this identification
Image courtesy of Pikist. Researchers based in Northern Italy recently took towards analyzing pathological features of infected lung tissue samples of thirty-eight deceased patients to
Art by Sophia Zhao. Can scientists predict how severely you’ll respond to COVID-19? A large coalition of researchers from Spain and Italy, studying DNA of
Image courtesy of Pixabay. Joining the race to discover an effective COVID-19 treatment, researchers are now looking towards investigating remdesivir, a broad-spectrum antiviral medication. In